Abstract 5267: Unbiased metabolic profiling of atypical teratoid/rhabdoid tumors predicts sensitivity to the glutamine metabolic inhibitor 6-diazo-5-oxo-L-norleucine
Sabrina Wang(Johns Hopkins Medicine), Jeffrey H. Rubens(Johns Hopkins University), Barbara Slusher(Johns Hopkins University), Brent A. Orr(St. Jude Children's Research Hospital), Antoinette Price(Johns Hopkins University), Eric H. Raabe(Johns Hopkins University), Jesse Alt(Johns Hopkins University), Sariah J. Allen(St. Jude Children's Research Hospital), Brad Poore(Johns Hopkins University), Rana Rais(Johns Hopkins University), Charles G. Eberhart(Johns Hopkins University)
Cited by 0
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711